Ehrlichiosis in Switzerland--significance for veterinary medicine

Ehrlichiosis is a rickettsial disease of animals and humans caused by various species of Ehrlichia. These obligate intracellular microorganisms infect granulocytes or monocytes of mammalian hosts and are transmitted mostly by ticks. The febrile disease is often undiagnosed and characterized by leukopenia, anemia and thrombocytopenia. The diagnosis of ehrlichiosis is based on clinical findings, tick infestation, direct or indirect detection of the agent, and serology. The role of native and imported ehrlichiae of animals in Switzerland is discussed.     

DNA vaccines for veterinary medicine

DNA vaccination represents one of the most recent novel approaches to vaccine development. Experimentally, DNA vaccines induce a broad range of long lasting immune responses including humoral and cell-mediated immunity against infectious diseases in humans and animals. Furthermore, DNA vaccines are potentially useful for the treatment of autoimmune diseases or cancer. However, most information on the efficacy of DNA vaccines has been generated in mice and studies in larger animals are limited. In this review, the potential application of DNA vaccines in livestock and pet animals are discussed. The principle of this new technology, its potency and future perspectives for use in veterinary medicine will be outlined.     

Nanoscience in veterinary medicine

Nanotechnology, as an enabling technology, has the potential to revolutionize veterinary medicine. Examples of potential applications in animal agriculture and veterinary medicine include disease diagnosis and treatment delivery systems, new tools for molecular and cellular breeding, identity preservation of animal history from birth to a consumer's table, the security of animal food products, major impact on animal nutrition scenarios ranging from the diet to nutrient uptake and utilization, modification of animal waste as expelled from the animal, pathogen detection, and many more. Existing research has demonstrated the feasibility of introducing nanoshells and nanotubes into animals to seek and destroy targeted cells. Thus, building blocks do exist and are expected to be integrated into systems over the next couple of decades on a commercial basis. While it is reasonable to presume that nanobiotechnology industries and unique developments will revolutionize veterinary medicine in the future, there is a huge concern, among some persons and organizations, about food safety and health as well as social and ethical issues which can delay or derail technological advancements.     

Maggot-therapy in veterinary medicine

Maggot-therapy is the application of disinfected fly larvae to chronic wounds to debride the wound bed of necrotic tissue, reduce bacterial contamination and enhance the formation of healthy granulation tissue. Interest in the use of maggot-therapy in human medicine is growing as a result of the prevalence of antibiotic resistant bacteria. Maggot therapy, however, is used relatively little in veterinary medicine. Nevertheless, concern over antibiotic resistance and the increase in demand for organic husbandry and residue-free meat and milk, suggest that it is an option which merits further consideration.